ROCTAVIAN
STN:125720
Proper Name: valoctocogene roxaparvovec-rvox
Tradename: ROCTAVIAN
Manufacturer: BioMarin Pharmaceutical Inc.
Indication:
- Indicated for the treatment of adults with severe hemophilia A (congenital factor VIII deficiency with factor VIII activity <1 IU/dL) without pre-existing antibodies to adeno-associated virus serotype 5 detected by an FDA-approved test.